IGFBP7 and cancer: Interestingly, suppression of TIMP1 in mice has been linked to maintenance and expansion of stem cells with no increased risk of cancer (Jackson et al., 2015), while the serum level of IGFBP7 is a marker of tissue aging and heart failure (Januzzi et al., 2018).